Background—
Platelet aggregation plays a critical role in myocardial infarction and stroke; however, the role of platelet secretion in atherosclerotic vascular disease is poorly understood. Therefore, we examined the hypothesis that platelet dense-granule secretion modulates thrombosis, inflammation, and atherosclerotic vascular remodeling after injury.
Methods and Results—
Functional deletion of the Hermansky-Pudlak syndrome 3 gene (HPS3 −/− ) markedly reduces platelet dense-granule secretion. HPS3 −/− mice have normal platelet counts, platelet morphology, and α-granule number, as well as maximal secretion of the α-granule marker P-selectin; however, their capacity to form platelet-leukocyte aggregates is significantly reduced ( P <0.05). To examine the role of platelet dense-granule secretion in these processes, atherosclerosis-prone mice with combined genetic deficiency of apolipoprotein E and HPS3 (ApoE −/− , HPS3 −/− ) were compared with congenic, atherosclerosis-prone mice with normal platelet secretion (ApoE −/− , HPS3 +/+ ). After 16 to 18 weeks on a high-fat diet, both groups of mice had similar fasting cholesterol levels and body weight. Carotid arteries of ApoE −/− , HPS3 +/+ mice thrombosed rapidly after FeCl 3 injury, but ApoE −/− , HPS3 −/− mice were completely resistant to thrombotic arterial occlusion ( P <0.01). Three weeks after injury, neointimal hyperplasia (from α-smooth muscle actin–positive cells) was significantly less ( P <0.001) in arteries from ApoE −/− , HPS3 −/− mice. In ApoE −/− , HPS3 −/− mice, there were also pronounced reductions in arterial inflammation, as indicated by a 74% decrease in CD45-positive leukocytes ( P <0.01) and a 73% decrease in Mac-3–positive macrophages ( P <0.05).
Conclusions—
In atherosclerotic mice, reduced platelet dense-granule secretion is associated with marked protection against the development of arterial thrombosis, inflammation, and neointimal hyperplasia after vascular injury.